Background/Aims: Epithelial ovarian cancer (EOC) is the sixth most commonly diagnosed cancer among women. Results with available therapies are far from being satisfactory and, therefore, current research is focusing on new anticancer drugs to improve the clinical response of these patients. Nintedanib is an oral multiple tyrosine kinases...
-
2019 (v1)PublicationUploaded on: January 31, 2024
-
2019 (v1)Publication
No description
Uploaded on: February 14, 2024 -
2020 (v1)PublicationPretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle
Research question: The major causes of IVF failure in women with endometriosis have been attributed to decreased ovarian reserve, low embryo quality and impaired receptivity of the endometrium. Dienogest (DNG) has anti-inflammatory and anti-angiogenic activity and so may theoretically improve IVF outcomes in women with endometriosis. This study...
Uploaded on: February 14, 2024 -
2019 (v1)Publication
Objective: To investigate the characteristics of women developing cervical intraepithelial neoplasia who had had a vaccination against human papillomavirus (HPV). Methods: A retrospective cohort study was carried out of women diagnosed with moderate or severe cervical dysplasia (CIN2+) in four Italian centers between 2015 and 2017. All women...
Uploaded on: March 27, 2023 -
2020 (v1)Publication
Ovarian cancer with complete clinical response recurs with a high rate. Recurrence is observed in almost 25% of cases with early-stage diseases and in more than 80% with more advance stages. Based on a platinum-free interval cut-off of 6 months, the first recurrence is usually classified in platinum-sensitive versus platinum-resistant,...
Uploaded on: February 14, 2024 -
2020 (v1)Publication
Objective: To evaluate the impact of various HPV types on the risk of developing lesions of the uterus (either uterine cervix and endometrium) in women diagnosed with "atypical glandular cells" (AGC) at Pap smear. Methods: This is a multi-institutional retrospective study. Data of women diagnosed with AGC were retrospectively reviewed. All...
Uploaded on: April 14, 2023 -
2020 (v1)Publication
Objective: Sentinel node mapping (SLNM) has replaced lymphadenectomy for staging surgery in apparent early-stage endometrial cancer (EC). Here, we evaluate long-term survival of three different approaches of nodal assessment in EC. Methods: This is a multi-institutional retrospective study evaluating long-term outcomes (at least 3 years) of EC...
Uploaded on: April 14, 2023 -
2020 (v1)Publication
Aim: During the last years, the role of sentinel lymph node mapping (SLNM) for endometrial cancer (EC) surgical treatment has increased in popularity. However, several controversies remain about different technical steps of SLNM. Thus, a randomised control trial was designed to compare cervical (CI) and hysteroscopic (HI) indocyanine green...
Uploaded on: April 14, 2023